Antihypertensive Drugs Market Statistics Report, 2021 | Global Industry Research on Growth, Trends and Opportunity in 202
Home HEALTHCARE Antihypertensive Drugs Market Statistics Report, 2021 | Global Industry Research on Growth, Trends and Opportunity in 202

Antihypertensive Drugs Market Statistics Report, 2021 | Global Industry Research on Growth, Trends and Opportunity in 202

Published by Editorial

The latest research report on Antihypertensive Drugs Market delivers a comprehensive study on current market trends.

The outcome also includes revenue forecasts, statistics, market valuations which illustrate its growth trends and competitive landscape as well as the key players in the business.

Antihypertensive Drugs Market is valued at USD 22.56 Billion in 2018 and expected to reach USD 26.82 Billion by 2025 with a CAGR of 2.5% over the forecast period.

Increasing irregular and unhealthy lifestyles are leading to hypertension and therefore, majorly driving the market growth.

Key Players for Global Antihypertensive Drugs Market Reports

Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, Astra Zeneca, Daiichi Sankyo, Takeda, Actelion, United Therapeutics, JW Pharmaceutical, Gilead, CJ Healthcare, Bayer, Boryung Pharmaceutical, Cipla and others.

Antihypertensives are a class of drugs that are used to treat high blood pressure that is hypertension. The hypertensive drugs seek to prevent the difficulties of hypertension as myocardial infarction (heart attack) and strokes. The anti-hypertension drugs are used for leveling or reducing blood pressure. Hypertension is a chronic condition, in which the blood pressure is elevated abnormally systolic as well as diastolic. This is major risk factor for causing cardiovascular, renal or endocrine disorders. The drugs comprise numerous classes of compounds with the therapeutic intention of preventing, controlling, or treating hypertension. The ultimate goal of antihypertensive drugs is to reduce cardiovascular morbidity and mortality. These are frequently used by patients and may influence conduct of anesthesia. These drugs have diverse indications, both cardiac and non-cardiac. Comparatively limited drug classes are used to treat hypertension, the newest among them are direct renin inhibitors. The renin–angiotensin system is targeted at different points by many of the commonly used antihypertensive drugs.

Antihypertensive Drugs market report is segmented on the basis of type, application and region & country level. Based upon type, antihypertensive drugs market is segmented into ARB, CCB and others. Based on application, antihypertensive drugs market is segmented into hypertension, PAH and others.

Key Benefits for Global Antihypertensive Drugs Market Reports 

• Antihypertensive Drugs Market report covers in-depth historical and forecast analysis.

• Antihypertensive Drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.

• Antihypertensive Drugs Market report helps to identify opportunities in marketplace.

• Antihypertensive Drugs Market report covers extensive analysis of emerging trends and competitive landscape.

The regions covered in this antihypertensive drugs market report are North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. On the basis of country level, the market of antihypertensive drugs market is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Get Sample Copy of This Premium Report 

Related Posts

We use cookies to improve user experience, and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By clicking “Accept Cookies,” you consent to store on your device all the technologies described in our Cookie Policy. Accept Read More